4.7 Article

Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication

Journal

JOURNAL OF MEDICINAL CHEMISTRY
Volume 51, Issue 16, Pages 5043-5051

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jm800332m

Keywords

-

Funding

  1. National Institute of Allergy and Infectious Diseases (NIAID) [1 R21 AI071802]
  2. National Institutes of Health, Bethesda, Maryland
  3. Nabi Biopharmaceuticals, Rockville, Maryland
  4. NIAID
  5. Intramural AIDS Targeted Antiviral Program (IATAP)

Ask authors/readers for more resources

series of ring expanded nucleoside (REN) analogues were synthesized and screened for inhibition of cellular RNA helicase activity and human immunodeficiency Virus type 1 (HIV-1) replication. We identified two compounds, 1 and 2, that inhibited the ATP dependent activity of human RNA helicase DDX3. Compounds 1 and 2 also Suppressed HIV-I replication in T cells and monocyte-derived macrophages. Neither compound at therapeutic doses was significantly toxic ill ex vivo cell culture or in vivo in mice. Our finding's provide proof-of-concept that a cellular factor, all RNA helicase. Could be targeted for inhibiting HIV-1 replication.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available